CryoText™ is a Wharton’s jelly or human umbilical cord product that is rich in cytokines, growth factors, and scaffolding proteins. It is used as a replacement tissue that is intended to replace missing or damaged connective tissue.
This is a connective tissue supplement intended for homologous use only, as described in 21CFR 1271.10(a). Structural connective tissue that is missing or damaged severely may require new or additional tissue to create conditions that encourage the stability of anatomic infrastructure. CryoText™ does not use any material obtained from the embryo or fetus. CryoText™ has high concentrations of hyaluronic acid and growth factors and is processed from human tissue, donated following full term, c-section deliveries, in accordance with the FDA.
35mg/mL Wharton’s jelly tissue product.
50mg/mL Wharton’s jelly tissue product.
A defect is defined as missing or damaged tissue in the body. Missing or damaged tissue often compromises the stability and structural integrity of its surrounding area. If you may be dealing with a structural defect, ask your physician if you could benefit from connective tissue supplementation.